Company joins Eli Lilly, Sanofi in capping prices in stateMultidistrict litigation over insulin costs remains ongoing
Novo Nordisk A/S on Monday became the final insulin manufacturer to reach a proposed settlement agreement with Minnesota, tentatively ending a seven-year lawsuit over the affordability of the diabetes medication.\